| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/04/2002 | US20020086841 Naked DNA construct encoding a cytokine selected from macrophage inflammatory protein-1 alpha, monocyte chemoattractant protein 1, and tumor necrosis factor-alpha, linked to a viral transcription control sequence, and carrier |
| 07/04/2002 | US20020086839 Inhibitors of DNA immunostimulatory sequence activity |
| 07/04/2002 | US20020086836 Cftr gene regulator |
| 07/04/2002 | US20020086825 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 07/04/2002 | US20020086823 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086822 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086821 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer |
| 07/04/2002 | US20020086817 Mannan-binding protein or gene; vaccinia virus vectors |
| 07/04/2002 | US20020086427 Inducible eukaryotic expression system that regulates protein translation |
| 07/04/2002 | US20020086426 Controlling gene expression; obtain cell, transform with expression vector, transcribe and monitor generation of tetracycline |
| 07/04/2002 | US20020086421 Tumor cells with increased immunogenicity and uses therefor |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086401 Nucleotide sequences coding transport protein; for use generating antiproliferative agents |
| 07/04/2002 | US20020086383 Cell expansion factor; for use in the treatment and prevention of graft rejection |
| 07/04/2002 | US20020086382 Nucleotide sequences coding membrane protein for use in the prevention and treatment of autoimmune diseases |
| 07/04/2002 | US20020086363 G-protein parathyroid hormone receptor HLTDG74 |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086031 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020086004 Especially wherein said angiogenic factor is an endothelial cell growth factor chosen from the FGF family of growth factors and the VEGF family of growth factors. |
| 07/04/2002 | US20020086003 Thymus reactivation, especially by administering hematopoietic stem cells |
| 07/04/2002 | US20020086002 Hematopoietic stem cell gene therapy |
| 07/04/2002 | US20020086001 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085999 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085989 Process of making a compound by forming a polymer from a template drug |
| 07/04/2002 | DE10065504A1 Adenoviral nucleic acid useful for preventing or treating malignant or benign tumors, by inducing cell lysis, comprises a sequence for the YB-1 protein |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2847458A1 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2433171A1 Human fgf23 protein mutants decreasing blood phosphorus level |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2432327A1 Screening method based on tsap6 binding partners |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2399280A1 Defects in periaxin associated with myelinopathies |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219709A1 Nucleozymes |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219303A1 Chondrogenesis promoters |
| 07/03/2002 | EP1218747A1 Method for identifying compounds useful in the therapy of bone disorders |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218528A1 Producer cell for the production of retroviral vectors |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218525A1 Utrophin gene promoter |
| 07/03/2002 | EP1218523A1 Targeted gene therapy |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218508A1 Gene treatment to enhance feed efficiency and growth rate of livestock |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218493A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218489A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 07/03/2002 | EP1218487A2 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218405A2 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
| 07/03/2002 | EP1218398A1 Antisense modulation of pi3 kinase p110 beta expression |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218395A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218035A2 Rapid peg-modification of viral vectors |
| 07/03/2002 | EP1218033A2 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 07/03/2002 | EP1218029A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 07/03/2002 | EP1218025A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 07/03/2002 | EP1217990A1 Cationic dosper virosomes |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1034292B1 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1356390A Human leukemia associated reverse transcription virus gene and its application |
| 07/03/2002 | CN1356259A Modified nano silicon particles |
| 07/02/2002 | US6414134 Regulation of bcl-2 gene expression |
| 07/02/2002 | US6414131 Nucleic acid sequence; schizophrenia, bipolar disorder and depression |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6413943 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 07/02/2002 | US6413942 Methods of delivering a physiologically active polypeptide to a mammal |
| 07/02/2002 | US6413941 Polymer composition for delivering a nucleic acid or derivative thereof |
| 07/02/2002 | US6413939 Inducible phosphofructokinase and the Warburg effect |
| 07/02/2002 | US6413933 Growth factor HTTER36 |
| 07/02/2002 | US6413776 High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413755 Human checkpoint kinase, HCDS1, compositions and methods |